Nu Skin Enterprises Files 10-Q for Q2 2024

TL;DR

NU SKIN 10-Q FILED: Q2 2024 financials are in. Check for performance updates.

AI Summary

Nu Skin Enterprises, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key financial figures and strategic initiatives are presented, reflecting the company's ongoing business activities and market position.

Why It Matters

This filing provides investors and analysts with a detailed look at Nu Skin's financial health and operational performance during the second quarter of 2024, influencing investment decisions.

Risk Assessment

Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and any disclosed risks within this report could impact the company's stock.

Key Numbers

• 7.44% — Variable 30 day rate (Indicates a fluctuating interest rate, potentially impacting financing costs.)
• 21% — Principal amount payable in installments (Shows a portion of debt is being paid down over a five-year period starting September 30, 2022.)

Key Players & Entities

• NU SKIN ENTERPRISES, INC. (company) — Filer of the 10-Q
• GREGORY BELLISTON (person) — Contact person for business and mail address
• 20240630 (date) — End of the reporting period
• 20240809 (date) — Filing date

FAQ

Filing Documents

• ef20029695_10q.htm (10-Q) — 1863KB
• ef20029695_ex31-1.htm (EX-31.1) — 11KB
• ef20029695_ex31-2.htm (EX-31.2) — 11KB
• ef20029695_ex32-1.htm (EX-32.1) — 4KB
• ef20029695_ex32-2.htm (EX-32.2) — 4KB
• 0001140361-24-036467.txt ( ) — 8876KB
• nus-20240630.xsd (EX-101.SCH) — 44KB
• nus-20240630_cal.xml (EX-101.CAL) — 63KB
• nus-20240630_def.xml (EX-101.DEF) — 290KB
• nus-20240630_lab.xml (EX-101.LAB) — 726KB
• nus-20240630_pre.xml (EX-101.PRE) — 463KB
• ef20029695_10q_htm.xml (XML) — 1689KB

Financial Statements (Unaudited)

Financial Statements (Unaudited): Consolidated Balance Sheets 1 Consolidated Statements of Income 2 Consolidated Statements of Comprehensive Income 3 Consolidated Statements of Stockholders' Equity 4 Consolidated Statements of Cash Flows 6

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 30 Item 4.

Controls and Procedures

Controls and Procedures 30 Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 31 Item 1A.

Risk Factors

Risk Factors 31 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 Item 3. Defaults Upon Senior Securities 31 Item 4. Mine Safety Disclosures 31 Item 5. Other Information 31 Item 6. Exhibits 32 Signature 33 In this Quarterly Report on Form 10-Q, references to "dollars" and "

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION ITEM 1.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS NU SKIN ENTERPRISES, INC. Consolidated Balance Sheets (Unaudited) (U.S. dollars in thousands) June 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 224,250 $ 256,057 Current investments 8,671 11,759 Accounts receivable, net 71,554 72,879 Inventories, net 243,994 279,978 Prepaid expenses and other 105,937 81,198 Total current assets 654,406 701,871 Property and equipment, net 411,918 432,965 Operating lease right-of-use assets 88,071 90,107 Goodwill 99,885 230,768 Other intangible assets, net 88,464 105,309 Other assets 243,228 245,443 Total assets $ 1,585,972 $ 1,806,463 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 36,305 $ 43,505 Accrued expenses 242,288 260,366 Current portion of long-term debt 30,000 25,000 Total current liabilities 308,593 328,871 Operating lease liabilities 70,318 70,943 Long-term debt 428,327 478,040 Other liabilities 92,570 106,641 Total liabilities 899,808 984,495 Commitments and contingencies (Notes 5 and 11) Stockholders' equity: Class A common stock – 500 million shares authorized, $ 0.001 par value, 90.6 million shares issued 91 91 Additional paid-in capital 621,440 621,853 Treasury stock, at cost – 40.9 million and 41.1 million shares ( 1,564,090 ) ( 1,570,440 ) Accumulated other comprehensive loss ( 116,995 ) ( 100,006 ) Retained earnings 1,745,718 1,870,470 Total stockholders' equity 686,164 821,968 Total liabilities and stockholders' equ ity $ 1,585,972 $ 1,806,463 The accompanying notes are an integral part of these consolidated financial statements. 1 Table of Contents NU SKIN ENTERPRISES, INC. Consolidated Income (Unaudited) (U.S. dollars in thousands, except per share amounts) Three Months Ended June 30 , Six Months Ended June 30, 2024 2023 2024 2023 Revenu

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 1. The Company Nu Skin Enterprises, Inc. (the "Company") is a holding company, with Nu Skin being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments —Americas, which includes Canada, Latin America and the United States; Mainland China; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand , Vietnam , Australia, New Zealand, and other markets; Japan; Europe and Africa, which includes markets in Europe as well as South Africa; South Korea; and Hong Kong/Taiwan, which also includes Macau—and two Rhyz segments—Manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz other, which includes other investments by its Rhyz business arm (the Company's subsidiaries operating within each segment are collectively referred to as the "Subsidiaries"). 2. Summary of Significant Accounting Policies The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for

View Full Filing

View this 10-Q filing on SEC EDGAR